BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 30269130)

  • 1. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor Lesions of Pancreatic Cancer.
    Kim JY; Hong SM
    Oncol Res Treat; 2018; 41(10):603-610. PubMed ID: 30269131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Pancreatic Cancer.
    Wada K; Takaori K; Traverso LW
    Surg Clin North Am; 2015 Oct; 95(5):1041-52. PubMed ID: 26315522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of Pancreatic Cancer Precursor Lesions.
    Noë M; Brosens LA
    Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Approaches to Pancreatic Cancer Screening.
    Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
    Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary intraductal papillary mucinous neoplasm of the pancreas.
    Denost Q; Chafai N; Arrive L; Mourra N; Paye F
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):e23-5. PubMed ID: 22225963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities.
    Lüttges J; Klöppel G
    Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial intraductal papillary mucinous neoplasms of the pancreas.
    Rebours V; Couvelard A; Peyroux JL; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
    Dig Liver Dis; 2012 May; 44(5):442-6. PubMed ID: 21824831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
    Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
    World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
    Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
    Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.
    Aronsson L; Andersson R; Ansari D
    Scand J Gastroenterol; 2017 Aug; 52(8):803-815. PubMed ID: 28446039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.
    Raut P; Nimmakayala RK; Batra SK; Ponnusamy MP
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188851. PubMed ID: 36535512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
    Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
    Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.